Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US69329Y1047
Ticker PDLI
Company PDL BIOPHARMA
Currency $
Price
Aware Investor Index (AII) 32.1673
Recommendation STRONG BUY
P/E 3.04
ROE 23.54 %
Capitalization 522,951,710 $
Dividend Yield 0.00 %
P/S 2.64
AII Position 72
P/E Position 10
ROE Position 125
Capitalization Position 703
Dividend Yield Position 594
Sales 198,110,000 $
10-Year Average Earnings 171,765,600 $
Shares Outstanding 145,669,000
Equity 729,779,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
PDL BIOPHARMA Investor Relations Web Site http://investor.pdl.com







Sales:

YEAR MONTH AMOUNT
2018 12 198,110,000.00 $
2017 12 320,060,000.00 $
2016 12 244,301,000.00 $
2015 12 590,448,000.00 $
2014 12 581,225,000.00 $
2013 12 442,921,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 -68,859,000.00 $
2017 12 110,748,000.00 $
2016 12 63,606,000.00 $
2015 12 332,795,000.00 $
2014 12 322,244,000.00 $
2013 12 264,530,000.00 $
2012 12 211,669,000.00 $
2011 12 199,389,000.00 $
2010 12 91,874,000.00 $
2009 12 189,660,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 729,779,000.00 $
2017 12 845,890,000.00 $
2016 12 755,423,000.00 $
2015 12 695,952,000.00 $
2014 12 460,437,000.00 $
2013 12 113,489,000.00 $
2012 12 -68,122,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 145,669,000
2017 12 156,257,000
2016 12 164,192,000
2015 12 163,554,000
2014 12 173,110,000
2013 12 159,343,000
2012 12 146,403,000

 












Bloomberg News for PDL BIOPHARMA:



Google News for PDL BIOPHARMA:

WestNewsNow - 2 days ago
PDL BioPharma (PDLI): This will sum up the whole Scenario
[NASDAQ: PDLI]: On March 21st, 2019, PDL BioPharma (NASDAQ:PDLI) opened trading at $3.7 and closed at $3.79 a share. This is a 2.43% ...
Zeeland Press
Booz Allen Hamilton Holding Corporation (BAH), PDL BioPharma ...
For shares of PDL BioPharma, Inc. (NASDAQ: PDLI), there are currently ratings available from 1 different stock market analysts who have all ...
Augusta Review
PDL BioPharma, Inc. (PDLI): Implausible Growth Acceleration
Price Performance of PDL BioPharma, Inc. (PDLI). When it comes to price performance, PDL BioPharma, Inc. (NASDAQ:PDLI) has had quite a ...
The EN Bulletin
Ignoring this can be a blatant mistake : PDL BioPharma, Inc. (PDLI)
Price Performance of PDL BioPharma, Inc. (PDLI). PDL BioPharma, Inc. (NASDAQ:PDLI) has had quite a remarkable price journey over the ...
FinBulletin - 2 days ago
Could Be A Good Medium-Term Play:: PDL BioPharma, Inc ...
On 15-03-2019 (Friday), PDL BioPharma, Inc., (NASDAQ: PDLI) closed at $3.55 in the latest trading session, marking a 2.01% ( Gain, ↑) move ...
FinBulletin - 4 days ago
Too Sour Or Too Delicious?: PDL BioPharma, Inc., (NASDAQ: PDLI ...
PDL BioPharma, Inc., belongs to Healthcare sector and Biotechnology industry. Intraday Trading of company: ...
The RNS Daily
PDL BioPharma, Inc. (PDLI) – it's time to buy. Check out key Indicators
Regarding PDL BioPharma, Inc. [PDLI] currently, the latest Wall Street ratings we can see is from the fiscal quarter that's going to end in ...
News Alarms
Reviewing PDL BioPharma Inc. (PDLI)'s and Provention Bio Inc ...
Both PDL BioPharma Inc. (NASDAQ:PDLI) and Provention Bio Inc. (NASDAQ:PRVB) are each other's competitor in the Biotechnology industry.
GV Times
Noticeable Analyst's ideas: PDL BioPharma, Inc. (PDLI)
USA based company, PDL BioPharma, Inc. (PDLI)'s latest closing price distance was 35.72% from the average-price of 200 days while it ...
FinBulletin - 25 Feb 2019
Alibaba Group Holding Limited (NYSE: BABA), PDL BioPharma, Inc ...
While Shares of PDL BioPharma, Inc. (NASDAQ: PDLI) constructed a change of 1.38% (Gain, ↑) and closed at $3.68. Alibaba Group Holding ...


Back